BioPharma
Servier's Phase 3 INDIGO trial shows positive results for vorasidenib in IDH-mutant Glioma
Clinically meaningful achievement of primary and secondary endpoints is first major advance in treatment of low-grade glioma in more than 20 years Endpo...
March 15, 2023 | News
Estrella Biopharma's ARTEMIS® T Cell Therapy EB103 IND Cleared by FDA for B-Cell Lymphomas Clinical Trial
Estrella Biopharma, Inc. ("Estrella"), a biopharmaceutical company whose mission is to harness the evolutionary power of the human immune system to transfo...
March 09, 2023 | News
JW Therapeutics Starts Clinical Trial of Carteyva® for High-Risk Large B-Cell Lymphoma
High-risk large B-cell lymphoma includes large B-cell lymphoma with International Prognostic Index (IPI) score ≥3, and high-grade B-cell lymphoma (HGBL)...
March 09, 2023 | News
Hummingbird Bioscience licenses Cancer Research UK's clinical trial results to support HMBD-001 development.
The Phase 1/2a clinical trial in the United Kingdom is being sponsored and managed by CRUK's Centre for Drug Development and led by Chief Investi...
March 06, 2023 | News
Harbour BioMed's Batoclimab Shows Positive Results in Phase III Trial for Myasthenia Gravis
Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel ant...
March 06, 2023 | News
ExoCoBio Obtains GMP Licenses for Exosome Biopharmaceuticals and HA Dermal Fillers
ExoGMP™ is the world's largest exosome manufacturing facility in Osong, South Korea. Cellosome™ HA fillers are expected to be approved ...
March 02, 2023 | News
Everest Medicines Commences Operations at State-of-the-Art mRNA Vaccine Facility.
Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercializa...
February 28, 2023 | News
Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase
In collaboration with researchers from the University of Shizuoka, Aji Bio-Pharma succeeded in developing a highly functional artificial RNA ligase using t...
February 23, 2023 | News
Biosyngen has obtained FDA IND clearance of BRG01 for Phase I/II clinical trials against Nasopharyngeal Cancer
Prior to this approval from the US FDA, Biosyngen's BRG01 was granted IND by China CDE on December 14th, 2022. In addition, China CDE has acknowledged...
February 18, 2023 | News
Boan Biotech's Investigational Long-acting Anti-IL-4Rα Antibody BA2101 Administered for First Patient in Phase I Clinical Trial
BA2101 is the first long-acting anti-IL-4Rα monoclonal antibody that enters the clinical trial stage in the country. It is intended to be used for tr...
February 16, 2023 | News
Boan Biotech's Investigational Anti-CD25 Antibody BA1106 Administered for First Patient in Phase I Clinical Trial
BA1106 is the first investigational anti-CD25 antibody to start clinical trials in China for treating solid tumors. Focusing on key therapeutic a...
February 13, 2023 | News
Nectin Therapeutics to Collaborate with Merck on a Clinical Trial of Anti-PVR Antibody NTX1088
Nectin Therapeutics Ltd. (Nectin), a biotechnology company developing novel targeted immunotherapies that address resistance to approved immune oncology tr...
February 08, 2023 | News
Amjevita™ (Adalimumab-atto), First Biosimilar to Humira®, Now Available in the United States
Amgen (NASDAQ:AMGN) announced AMJEVITA™ (adalimumab-atto), a biosimilar to Humira®* (adalimumab), is now available in the Un...
February 01, 2023 | News
KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced it entered into a subcontract with Mapp Biopharmaceutical, Inc. (Mapp) for the cont...
January 23, 2023 | News
Most Read
- Companies Embracing Rebranding in Biotech, Life Sciences, and Biopharma
- China-Africa medical cooperation broadens under BRI
- Singapore's National University Health System Launches World's First Public Hospital Healthy Longevity Clinic
- Innovac Therapeutics Secures $18M Pre-A Funding for Lead Program Development
- Sirnaomics' STP707 Shows Promise in Phase I Solid Tumor Study
- Agilent Receives European IVDR Certification for Companion Diagnostic Assay
- BioSkryb Genomics Partners with Research Instruments: Bringing Single-Cell Tech to Singapore & Southeast Asia
- Thermo Fisher Launches 'Made in India' TSV Series Lab Refrigerators and Freezers
Bio Jobs
- New Survey Reveals Insights on Singapore Workers' Preparedness for Digital Transformation
- Danaher Careers - Search Global Science and Technology Jobs
- Suvoda Expands Board of Directors With Addition of Clinical Trial Veteran Irena Webster
- Careers at MERCK Group
- Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility
- Veranova Appoints Mike Riley as Chief Executive Officer
- Find your Job at Eppendorf
News
Editor Picks
